• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FRESENIUS VIAL S.A.S. VOLUMAT MC AGILIA E; INFUSION PUMP SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FRESENIUS VIAL S.A.S. VOLUMAT MC AGILIA E; INFUSION PUMP SYSTEM Back to Search Results
Catalog Number Z019180
Device Problem No Apparent Adverse Event (3189)
Patient Problem Extravasation (1842)
Event Date 03/07/2023
Event Type  malfunction  
Event Description
The following has been reported: "there was an extravasation in the peripheral line during the administration of serum therapy and magnesium sulfate and the sato2 alarm of the pump did not go off.The therapy started 15 minutes ago, since the alarm was not activated, the pumps continued perfusing.Consequence: the incident has caused harm to the patient.The patient suffered pain, induration, swelling of the hand and the forearm, as well as cyanosis and bleach the fingers out." reporting due to the referenced issue; no further information regarding the patient's status was communicated.More information is needed to complete the investigation.
 
Event Description
Device history record was reviewed and nothing was found related to the reported event.Device log was reviewed but data is insufficient to confirm the reported event.The reported device was returned to brézins for investigation.Several tests such as pressure accuracy - occlusion alarm accuracy- accuracy flow rate measurement : were performed.All results were compliant with ifu values specifications.No functional or technical issue could be detected upon device investigation.For a better detection in case of partial occlusion (extravasation) a pressure parameters adjustment is recommended (with lower threshold and dps increase activation).Cases of extravasation (intraveinous line not in the veinous system ) can be linked to several causes such as incorrect introduction of the needle, patient movement, rupture of the vein,.However the specifications of our pumps do not outline that they should detect a wrong insertion of the iv line leading to an extremely low flowrate.This hazardous situation is outside fk responsibility regarding this kind of event which is not related to the functionality of the device.This complaint is considered as not valid.For this issue as per our local procedure, we initiated no action.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VOLUMAT MC AGILIA E
Type of Device
INFUSION PUMP SYSTEM
Manufacturer (Section D)
FRESENIUS VIAL S.A.S.
le grand chemin
brezins, 38590
FR  38590
Manufacturer (Section G)
FRESENIUS VIAL S.A.S.
le grand chemin
brezins, 38590
FR   38590
Manufacturer Contact
rebecca mccandless
3 corporate drive
lake zurich, IL 60047-8930
8475502913
MDR Report Key16678350
MDR Text Key313203476
Report Number3000240707-2023-00088
Device Sequence Number1
Product Code FRN
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
K121613
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 07/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/04/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue NumberZ019180
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received03/08/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/05/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-